Literature DB >> 7603595

Localised proton spectroscopy and spectroscopic imaging in cerebral gliomas, with comparison to positron emission tomography.

K G Go1, R L Kamman, E L Mooyaart, M A Heesters, J Pruim, W Vaalburg, A M Paans.   

Abstract

In 32 patients with gliomas, one- and two-dimensional proton magnetic resonance spectroscopy (1H-MRS) has been conducted, the latter allowing reconstruction of spectroscopic data into a spectroscopic image (MRSI), showing the distribution of the various metabolite concentrations over the cross-sectional plane. For lack of absolute concentrations, the measured concentrations of phosphocholine (CHOL), N-acetyl-L-aspartate (NAA), and lactate (LAC) were conventionally expressed in ratios relative to that of creatine (CREAT). Compared to normal brain tissue, an increased CHOL/CREAT ratio was found in all groups of tumours, in glioblastomas, high-, middle- and low-grade astrocytomas both at the margin and the core of the tumours, but in oligodendrogliomas only at the margin. This is consistent with an increased phosphocholine turnover in relation to membrane biosynthesis by the proliferating cells. The NAA/CREAT ratio was decreased in all groups of tumours, both in the centre and at the margin, reflecting replacement of functioning neurons by neoplastic cells. The LAC/CREAT ratio was elevated in the core of malignant gliomas, which may be the result of a prevailing glycolysis, characteristic of tumours, possibly in conjunction with hypoxia/ischaemia. In the perifocal oedema, there was neither elevation of the CHOL/CREAT ratio nor decrease of the NAA/CREAT ratio; an increased LAC/CREAT ratio therefore rather reflected ischaemia/hypoxia probably due to locally elevated pressure and compromised regional perfusion. In the normal brain, the metabolite ratios of grey matter did not differ from those of white matter. The frontal lobe and basal ganglia showed lower NAA/CREAT ratios than the other cerebral areas.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603595     DOI: 10.1007/BF01578258

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  34 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Human brain infarction: proton MR spectroscopy.

Authors:  J H Duijn; G B Matson; A A Maudsley; J W Hugg; M W Weiner
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

3.  Correlation of experimental and clinical studies of metabolism by PET scanning.

Authors:  P L Kornblith; C J Cummins; B H Smith; R A Brooks; N J Patronas; G Di Chiro
Journal:  Prog Exp Tumor Res       Date:  1984

Review 4.  N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain.

Authors:  D L Birken; W H Oldendorf
Journal:  Neurosci Biobehav Rev       Date:  1989       Impact factor: 8.989

5.  Measurement of brain pH using 11CO2 and positron emission tomography.

Authors:  R B Buxton; L R Wechsler; N M Alpert; R H Ackerman; D R Elmaleh; J A Correia
Journal:  J Cereb Blood Flow Metab       Date:  1984-03       Impact factor: 6.200

6.  Peri-tumoural hypoxia in human brain: peroperative measurement of the tissue oxygen tension around malignant brain tumours.

Authors:  G S Cruickshank; R Rampling
Journal:  Acta Neurochir Suppl (Wien)       Date:  1994

7.  Human brain tumors: assessment with in vivo proton MR spectroscopy.

Authors:  D Ott; J Hennig; T Ernst
Journal:  Radiology       Date:  1993-03       Impact factor: 11.105

8.  Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET).

Authors:  J M Bolster; W Vaalburg; A M Paans; T H van Dijk; P H Elsinga; J B Zijlstra; D A Piers; N H Mulder; M G Woldring; H Wynberg
Journal:  Eur J Nucl Med       Date:  1986

9.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.

Authors:  H Bruhn; J Frahm; M L Gyngell; K D Merboldt; W Hänicke; R Sauter; C Hamburger
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

10.  Biochemical investigation of human tumours in vivo with phosphorus-31 magnetic resonance spectroscopy.

Authors:  R D Oberhaensli; D Hilton-Jones; P J Bore; L J Hands; R P Rampling; G K Radda
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

View more
  7 in total

1.  Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.

Authors:  Xiaojuan Li; Daniel B Vigneron; Soonmee Cha; Edward E Graves; Forrest Crawford; Susan M Chang; Sarah J Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

2.  Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.

Authors:  James S Cordova; Hui-Kuo G Shu; Zhongxing Liang; Saumya S Gurbani; Lee A D Cooper; Chad A Holder; Jeffrey J Olson; Brad Kairdolf; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Hyunsuk Shim
Journal:  Neuro Oncol       Date:  2016-03-15       Impact factor: 12.300

3.  The nonspecific nature of proton spectroscopy in brain masses in children: a series of demyelinating lesions.

Authors:  H G Pandya; I D Wilkinson; S K Agarwal; P D Griffiths
Journal:  Neuroradiology       Date:  2005-03-18       Impact factor: 2.804

4.  In vivo 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements.

Authors:  J M Star-Lack; E Adalsteinsson; M F Adam; D J Terris; H A Pinto; J M Brown; D M Spielman
Journal:  AJNR Am J Neuroradiol       Date:  2000-01       Impact factor: 3.825

Review 5.  Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.

Authors:  Sarah J Nelson
Journal:  NMR Biomed       Date:  2011-04-27       Impact factor: 4.044

Review 6.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 7.  Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.

Authors:  Patrick-Denis St-Coeur; Mohamed Touaibia; Miroslava Cuperlovic-Culf; Pier Morin
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-06-01       Impact factor: 7.691

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.